Holoclara is a Freeflow Fund One portfolio company that discovers, develops and commercializes novel therapeutics based on secretions from nematodes (roundworms). The company is led by Founder & CEO Andrea Choe who received her MD at USC Keck School of Medicine and her PhD at Caltech. Her doctoral work on the evolution of roundworm pheromones laid the foundation for the technology at Holoclara.

This discussion took place on Wednesday, October 30, 2024.